Wang S - Search Results

1

MRI evaluation of extramural vascular invasion by inexperienced radiologists.

Wang S, Li XT, Zhang XY, Sun RJ, Qu YH, Zhu HC, Guan Z, Sun YS. Wang S, et al. Br J Radiol. 2019 Dec;92(1104):20181055. doi: 10.1259/bjr.20181055. Epub 2019 Oct 23. Br J Radiol. 2019. PMID: 31596129 Free PMC article.

2

MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival.

Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, Wu AW, Sun YS. Zhang XY, et al. Among authors: wang l, wang s, wang yp. Radiology. 2018 Dec;289(3):677-685. doi: 10.1148/radiol.2018172889. Epub 2018 Aug 28. Radiology. 2018. PMID: 30152742

3

Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: A prospective single-center study.

Zhu HB, Zhang XY, Zhou XH, Li XT, Liu YL, Wang S, Sun YS. Zhu HB, et al. Among authors: wang s. J Magn Reson Imaging. 2017 Jul;46(1):175-183. doi: 10.1002/jmri.25567. Epub 2016 Dec 16. J Magn Reson Imaging. 2017. PMID: 27981667 Clinical Trial.

4

Rapid screening for individualized chemotherapy optimization of colorectal cancer: A novel conditional reprogramming technology-based functional diagnostic assay.

Li Y, Guo D, Zhang Y, Wang L, Sun T, Li Z, Zhang X, Wang S, Chen Y, Wu A. Li Y, et al. Among authors: wang l, wang s. Transl Oncol. 2021 Jan;14(1):100935. doi: 10.1016/j.tranon.2020.100935. Epub 2020 Nov 12. Transl Oncol. 2021. PMID: 33190042 Free PMC article.

5

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.

Shen Y, Han X, Wang J, Wang S, Yang H, Lu SH, Shi Y. Shen Y, et al. Among authors: wang j, wang s. Sci Rep. 2016 Apr 14;6:24310. doi: 10.1038/srep24310. Sci Rep. 2016. PMID: 27074743 Free PMC article.

6

[Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].

Wang S, Han XH, Li JL, Hu XS, Wang XY, Gui L, Zhao LD, Sun Y, Shi YK. Wang S, et al. Among authors: wang xy. Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):530-3. doi: 10.3760/cma.j.issn.0529-5807.2012.08.005. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23157744 Chinese.

7

Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer.

Wang J, Yang H, Shen Y, Wang S, Lin D, Ma L, Han X, Shi Y. Wang J, et al. Among authors: wang s. Cancer Biomark. 2013;13(2):89-97. doi: 10.3233/CBM-130334. Cancer Biomark. 2013. PMID: 23838137

8

Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.

Shen Y, Wang J, Han X, Yang H, Wang S, Lin D, Shi Y. Shen Y, et al. Among authors: wang j, wang s. PLoS One. 2013 Dec 10;8(12):e81628. doi: 10.1371/journal.pone.0081628. eCollection 2013. PLoS One. 2013. PMID: 24339949 Free PMC article.

9

Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers.

Li N, Song Y, Du P, Shen Y, Yang J, Gui L, Wang S, Wang J, Sun Y, Han X, Shi Y. Li N, et al. Among authors: wang j, wang s. Biomed Pharmacother. 2013 Oct;67(8):801-6. doi: 10.1016/j.biopha.2013.08.002. Epub 2013 Sep 12. Biomed Pharmacother. 2013. PMID: 24074809 Clinical Trial.

10

[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection].

Qian X, Wang S, Shen Y, Wu D, Zhang Z, Feng Y, Han X, Shi Y. Qian X, et al. Among authors: wang s. Zhonghua Yi Xue Za Zhi. 2015 Jan 13;95(2):106-11. Zhonghua Yi Xue Za Zhi. 2015. PMID: 25876895 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109,525 results

Search Page